Find your path to Eliseo
163 people in our graph share verified history with Eliseo — schools, employers, funds. One of them is your warm intro.
Michael TaylorunlockedEliseo: together at Wyeth Pharmaceuticals (1993–2004)
×9Eliseo: together at Wyeth Pharmaceuticals
×2Eliseo: together at Elan Pharmaceuticals
President and Chief Scientific Officer at Relmada Therapeutics
Intro paths
→
In turn, Eliseo can intro founders to Relmada Therapeutics's investors below.
Relmada Therapeutics's investors · 9
BAM ElevateChicago · since 2026BioAdvanceConshohocken · $500K – $1.5M checksBraidwellStamford · since 2026Commodore CapitalNew York · since 2026Janus Henderson InvestorsLondon · since 2026OrbiMedNew York · $1M – $75M checks · since 2026RA CapitalBoston · since 2026VenrockPalo Alto · $500K – $10M checks · since 2026Venrock Healthcare Capital PartnersNew York · since 2026
Experience
- Delix TherapeuticsHead of Research And Developmentcurrent2022 — presentBoston, Massachusetts, United States
- Yemanjá LLCOperating Managercurrent2022 — presentPhiladelphia, Pennsylvania, United States
- Passage BioChief Research & Development Officer2021 — 2022Philadelphia, Pennsylvania, United States
- ACADIA Pharmaceuticals Inc.Chief Scientific Officer, SVP Translational Research & External Innovation2018 — 2021Princeton, NJ, USA
- New World LaboratoriesChief Medical Officer2018Montreal, Canada
- Eliseo Salinas ConsultingPharmaceutical Consultant2017 — 2018NYC area
- Turing Pharmaceuticals AGInterim Chief Executive Officer - President R&D2017NYC, NY.
- Turing Pharmaceuticals AGPresident Research & Development2015 — 2017
- Relmada TherapeuticsPresident & Chief Scientific Officer2014 — 2015New York City
- StemCells, Inc.Executive Vice President - Head of Research & Development2013 — 2014San Francisco Bay Area
- StemCells, Inc.Advisor - Product Development Strategy2012 — 2013Newark, CA
- Elan PharmaceuticalsChief Medical Officer - Head of Development2010 — 2012
- AdolorChief Medical Officer2008 — 2010
- Shire PharmaceuticalsChief Scientific Officer - Head of Research & Development2004 — 2008Greater Philadelphia
- Wyeth PharmaceuticalsVice President CR&D - 1: Head of CNS / 2: Head of Field Ops Americas / 3: Portfolio Japan1993 — 2004Greater Philadelphia
Skills & more
Clinical Development86Pharmaceutical Industry35Biotechnology36Regulatory Affairs21Clinical Research19Pharmacovigilance11Medical Affairs13Validation6Pharmaceutics10Medicine5Translational Medicine8Cell2
+8 more
LeadershipProduct DevelopmentStrategic PlanningProject ManagementManagementClinical TrialsLifesciencesDrug DevelopmentLanguages French · Portuguese (conversational) · Spanish
From Eliseo's professional profile.
Frequently asked questions
- Who is Eliseo O. Salinas?
- President and Chief Scientific Officer at Relmada Therapeutics
- Where does Eliseo O. Salinas work?
- Eliseo O. Salinas is President and Chief Scientific Officer at Relmada Therapeutics.
- Where did Eliseo O. Salinas go to school?
- Eliseo O. Salinas studied at Université Pierre et Marie Curie, Paris, France (Master of Science - Pharmacology, Pharmacology and Toxicology); Univ of Buenos Aires Med School / Hopitaux Psychiatriques de la Region Parisienne (Doctor of Medicine (MD) / Psychiatrist, Medicine).
Shared employers
Also worked at Passage Bio3
Also worked at ACADIA Pharmaceuticals Inc.6
Edny InuiInvestor at Palo Santo VCDamien McDevittPresident and Chief Executive Officer at Aspen NeuroscienceMichael MagnaniExecutive Officer, Director at SaranasErin FoffExecutive Officer at MapLight TherapeuticsRob AcklesChief People Officer at AdarxKimberly J. ManhardExecutive Vice President, Chief Development Officer at Connect Biopharma
Also worked at StemCells, Inc.2
Also worked at Elan Pharmaceuticals22
Carlos PayaVenture Partner at Ysios CapitalLars EkmanExecutive Partner, Private Equity at Sofinnova VenturesDeclan KellyCFO at Delta PartnersDaniel O'MahonyPartner at Seroba Life SciencesAlan O'ConnellPartner at Seroba Life SciencesGeorge GolumbeskiPartner at Droia Ventures
+ 16 more